intimidated by transaxillary augmentation mammoplasty (TAM) because positioning the implants can be difficult. Regardless, TAM provides another option for patients who wish to avoid breast incisions.
The senior author (J.G.) conducted a chart review to determine (1) whether nonendoscopic subpectoral TAM produces high patient satisfaction, as measured by the BREAST-Q patient-reported outcome measure (BQ) [1] [2] [3] [4] [5] [6] [7] ; (2) whether the associated complication rates are comparable to those of other studies [8] [9] [10] [11] [12] [13] [14] ; and (3) if reoperation rates are higher for saline implants (because of deflations) than for silicone gel implants.
To the authors' knowledge, this is the first study to utilize the BQ to assess patient satisfaction and quality of life (QOL) in a long-term study of postoperative BA patients.
MEthOdS
From January 1, 2002, to December 31, 2011, the senior author conducted a retrospective chart review that represented 10 years of patient experience (n = 2430 for primary BA; 4860 implants). He compared outcomes from saline implants placed with different techniques during the final 5 years of the moratorium of the US Food and Drug Administration (phase 1 of the study) with outcomes from both gel and saline implants placed during the 5 years after the moratorium was lifted (phase 2 of the study). 15, 16 The patients were consecutive.
Phase 1 (January 1, 2002-December 31, 2006) comprised 1172 patients who received cosmetic saline implants at several ambulatory surgery centers. Phase 2 (January 1, 2007-December 31, 2011) comprised 1258 patients who received cosmetic gel or saline implants at the same clinics. The patients in both phases accounted for all of author's patients who underwent primary BA during the study periods.
Patient-reported perspectives (measured with the BQ) were requested from all patients, including those who underwent secondary procedures. If the axillary approach had been documented as at least 1 of the methods of bilateral implant placement, the case was considered axillary.
This study was approved by the Institutional Review Board of the University of Minnesota, Minneapolis, MN (Study No. 1111M07181).
BReast-Q
Although traditional metrics remain relevant, an evidencebased approach to surgical practice and measuring patientreported outcomes has become increasingly important. 17 Patient satisfaction was measured with the BQ, 1-7 a patientreported outcome measure that assesses patient perceptions of outcomes in breast surgery. This measurement tool has been validated and reliably quantifies satisfaction and QOL. Our study utilized 2 categories from the postoperative augmentation module of the BQ: patient satisfaction and patient outcomes. All BQ scores ranged from 0 to 100.
A cross-sectional survey was administered to all BA patients retrospectively. An attempt was made to contact the entire 10-year cohort by telephone. Permission to mail the BQ questionnaire was obtained from all 1003 patients who were reachable by telephone. All patients who could be contacted gave permission to mail the questionnaire. Surveys were completed anonymously. The type of implant and type of procedure were tracked for each questionnaire. The BQ score was calculated using the Q-score program, which converts raw survey scores of 1 through 4 to scores of 0 to 100. Higher scores denote greater satisfaction or better healthrelated QOL. Follow-up time ranged from 1 to 11 years.
axillary vs Nonaxillary Incisions
Satisfaction was compared between BA patients who had axillary incisions (TAM; n = 543) and those who had visible incisions on the breasts (inframammary, periareolar, or mastopexy; n = 127). The BQ scores for breast satisfaction and outcome satisfaction were compared between surgical groups using the median and interquartile range. (The interquartile range is a measure of statistical dispersion of data that are resistant to outliers and is calculated as a range within the 25th and 75th percentiles.) Because the distributions were strongly skewed to the left, the median BQ scores for breast satisfaction and outcome satisfaction were compared between these surgical groups with the 2-sample Wilcoxon signed rank test.
During phase 1 of the study, the senior author (J.G.) performed 1172 cosmetic BA procedures, exclusively with saline implants (2344 implants); during phase 2, he performed 1258 cosmetic BA procedures with gel or saline implants (2516 implants). Thus, the total number of patients who underwent primary BA during the 10-year study period was 2430 (4860 implants). The entire group and the axillary cohort were assessed for the following outcomes and revisions: deflation, size change, malposition, change from saline to silicone, capsular contracture (CC), explant, hematoma, subsequent mastopexy, lipotransfer (visible wrinkling), partial closure (skin separation), infection, explant with breast reduction, and insertion of a secondary implant.
Surgical outcomes for gel and saline implants used in phase 2 were compared. Based on the senior author's previous outcomes with gel implants (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) , the patients in phase 2 had been advised preoperatively that the visual result would be equivalent for saline or silicone implants. All clinic personnel followed a standardized checklist to ensure that the same preoperative discussion was held with each patient and included the pros and cons of saline and gel implants. Patients were allowed to "try on" and palpate gel and saline implants and ultimately selected their preferred device. The choice of implant type is treated as an "explanatory (independent) variable" in this study.
The following information was documented for all patients in the study: preoperative breast measurements, postoperative breast measurements, age, date of surgery, and implant size/type/manufacturer.
Preoperative assessments
Tissue-based planning was provided for all patients. Patients with normal breast anatomy were given the choice of inframammary, periareolar, or axillary incisions. Inclusion criteria for TAM were patients with normal breast anatomy who chose the axillary incision. Exclusion criteria included ptosis, pseudoptosis, or tuberous components; a center-point of the nipple-areola complex (NAC) down to approximately the level of the inframammary fold (IMF); a constricted lower pole (NAC-IMF <5 cm); or a tight IMF (Figure 1 ). Assessments were made from these measurements to determine which patients would be best served by straightforward BA, dual-plane BA, or mastopexy. 18 When formulating the surgical plan, the surgeon was careful to compensate for preoperative size differences, especially if saline implants were chosen. Each patient was asked whether she noticed any size difference when wearing a bra. Any difference in size between the 2 breasts was ascertained with the patient in the supine, forwardleaning, and standing positions (Figure 2A-C) . Patient photographs were then printed and analyzed for size differences. For patients who selected gel implants, in some cases, the difference in breast size could be addressed by using gel implants of different sizes. If the manufacturer produces those sizes, then gel implants were often placed in such a manner to achieve adequate volume symmetry. If saline implants were chosen, volume adjustments were made during surgery to compensate for a size discrepancy between the breasts ( Figure 3A,B) .
Patients who met the inclusion criteria were asked to choose between the 3 incision locations, with the understanding that a scar may be present at that location for the rest of their life. Preoperative measurements and potential tissue cover were the greatest factors for determining selection of implant size. The patient's personal requests were considered as well.
Once the procedure was scheduled, the patient was given an instruction card that contained important directions such as avoiding blood thinners and nicotine in the perioperative period. Strict, reliable methods of birth control were discussed, and all patients signed a legal release regarding potential pregnancy. Patients were instructed to wash with 4% chlorhexidine gluconate soap for a total of 3 preoperative showers, taken at least 1 hour apart, starting the evening before surgery and ending the morning of surgery. Patients were advised to scrub the torso to reduce the number of skin contaminants.
taM surgical technique
Two videos (1 for gel, 1 for saline) that include detailed descriptions of the senior author's technique may be viewed at www.aestheticsurgeryjournal.com or www.surgery.org/videos. A detailed description of the operative technique also is available as a supplementary online text file (at www.aestheticsurgeryjournal.com).
With the TAM approach, it is possible to place large gel implants. An important aspect of TAM is the nonuse of sizers. (Sizers are routinely used by the author in secondary breast surgery.) Once dissection of the pocket was accomplished, air was drawn into the pocket by gently elevating the gland off the ribs with a dissector (Figure 4A-C) . The incision was manually pinched closed. Thus, the outline of the pocket perimeter was delineated, obviating the need for a sizer. Following the "air-sizer" maneuver, any pocket irregularities were modified as necessary. Care was taken to adequately stretch the muscle fibers medially.
Postoperative Care for IMF Migration and Double Fold
Occasionally, a shoelace was utilized to "set" the IMF if inferior migration of the implant occurred ( Figure 5A -C). 8 It is important to slightly overcorrect by setting the shoelace 1 to 2 cm higher than the contralateral normal crease, because the reestablished IMF will relax slightly over time. This focal compression allowed manipulation of the IMF Figure 1 . This 24-year-old woman demonstrates 3 contraindications to axillary BA because (1) she has 10% to 15% pseudoptosis with breast tissue existing below the IMF (note pink card as a reference point); (2) her NAC, even though it is slightly above the IMF, is set low on the breast mound; and (3) she has a tight IMF. She ultimately had a dual-plane BA to correct these preoperative findings. and sealing of the pocket at the desired location. Patients were instructed to wear the shoelace 7 days a week, 24 hours a day, for the first postoperative month (or longer, if necessary), except when bathing or showering. (Only anecdotal evidence is available to support this practice.) Some patients discontinued wearing the shoelace after they complained of pain and the fact that the shoelace could be visible around the neck.
A deformity that occurred in some patients was a tight crease, which maintained its original tight contour and resisted expansion by the underlying implant, causing flattening along its original length and producing a double fold. A cutout bra was applied to treat the tight crease. If a cutout bra was recommended, the patient was instructed to bring in a standard, inexpensive underwire bra without gel or padding. The lower half of the cup, from immediately above the underwire up to the NAC level, was cut away with scissors. As with the shoelace, patients were instructed to wear the cutout bra 7 days a week, 24 hours a day, for the first postoperative month (or longer, if necessary), except when bathing or showering. The cutout bra expands the tight IMF because the wire compresses the new IMF and allows the original fold to relax more superiorly. With this method, the author has found that most taut tissue will succumb to the implant forces and efface during a period of 1 to 3 months. Patient photos outline this method in a prior publication. Postoperative Routine: arm Bands and CC avoidance
In an effort to avoid tight bands from forming in the upper arms, and as a method of massage to help prevent CC, all patients were instructed to begin raising their arms over their heads and to perform displacement exercises beginning a few hours after surgery ( Figure 6A ,B). Patients were instructed to lie face down on a hard surface (such as a carpeted floor, or a bread board in bed) for 15 minutes each day. Regardless of the surgeon's preferred massage routine to avoid CC, patients were encouraged to continue these exercises for years, rather than weeks or months.
evaluations
Clinical photographs and the BQ were used to evaluate outcomes. Five standardized photographs were obtained preoperatively and postoperatively for all patients; frontal, side, and oblique views were included. Preoperatively, the surgeon analyzed the photographs, along with the patient, for asymmetries and ptosis. All postoperative photographs were analyzed and compared with the respective preoperative images by 2 independent evaluators (the clinic registered nurse and the aesthetician) and by the surgeon. Postoperative photographs were reviewed personally with all patients in the clinic by the registered nurse and the surgeon, and were given to the patient upon request.
RESuLtS
Clinical results for 2 patients (1 each for moderate-profile saline and gel implants) are shown in Figures 7 and 8. Overall, 2000 patients underwent TAM (82.3% of the study population): 994 patients in the first phase of the study (84.8% of phase 1 cohort) and 1006 in the second phase (545 with saline implants, 461 with gel implants; 79.9% of phase 2 cohort).
Patient Demographics
The mean age (SD) of all patients (n = 2430) was 33.5 (8.6) years (range, 18-69 years; Figure 9 ). The median age was 32.8 years. The mean age (SD) of the axillary cohort (n = 2000) was 32.8 (8.5) years (range, 18-69 years). The median overall age was 32.1 years. The overall interquartile range was 26.9 to 39.0 years, and the interquartile range for the axillary cohort was 26.1 to 37.9 years, . She was pain-free and was not taking medication. To avoid CC and the formation of arm bands, we instruct all patients to begin raising their arms over their heads and performing displacement exercises, starting several hours after surgery. This patient was demonstrating her routine arm exercises ("the wave"). (B) This 33-year-old woman (5'9" tall, 160 pounds) appeared satisfied when seen in the office 24 hours after TAM in which 420-cc saline implants were placed (McGhan/Inamed/Allergan, Irvine, CA). She was pain-free, was not taking medication, and was demonstrating her routine arm exercises ("the wave").
reflecting a slightly younger axillary group. Both cohorts included different ethnicities based on the surgeon's geographical area, but ethnicity was not specifically recorded.
Implant Characteristics
Initially, each patient received 2 implants (1 in each breast). The average implant size (SD) for the entire study population was 354.3 (63.2) cc (range, 150-800 cc; Figure  10 ). The overall median size was 360 cc. For the axillary cohort, the average implant size (SD) was 354.4 (61.2) cc (range, 180-800 cc) and the median size was 360 cc (same as the overall median size). The interquartile range was 304 to 390 cc for both groups. All implants placed throughout the study were smooth, round, medium-or high-profile devices from McGhan/Inamed/Allergan (Irvine, CA) (98% overall) or from Mentor Worldwide LLC (Santa Barbara, CA) (2%; last 3 months of the study).
BReast-Q: Measuring Postoperative Outcomes From the Patient Perspective for Breast satisfaction and Outcome satisfaction
The BQ cohort (n = 670) was analyzed for postoperative breast satisfaction and overall satisfaction with outcomes; follow-up ranged from 1 to 11 years ( Table 1 ). The BQ mean score (standard deviation [SD]) for postoperative breast satisfaction among these patients was 76.0 (16.6) ( Table 2 ). The mean (SD) score for overall outcome satisfaction for these patients was 80.4 (22.4) ( Table 3) .
Satisfaction: Axillary (tAM) vs Nonaxillary Incisions
The BQ-reported median scores for breast satisfaction and outcome satisfaction differed between the axillary (n = 543) and nonaxillary (n = 127) groups. For the axillary incision group, median scores were 77.0 and 86.0 for breast satisfaction and outcome satisfaction, respectively. For the nonaxillary incision group, the median scores were 70.0 and 70.0, respectively. The respective interquartile ranges were 23.0 and 30.0 vs 21.0 and 33.0. The differences between the median scores in the axillary and nonaxillary surgical groups for BQ-reported breast satisfaction and outcome satisfaction were statistically significant (W = 32 894.5, P < .0001 [ Table 4 ]; W = 31 201.5, P < .0001, respectively [ Table 5 ]).
Correlation Between Satisfaction and Outcomes
Correlation analysis was used to describe the linear relationship between breast satisfaction scores and outcome satisfaction scores. The Pearson correlation coefficient for these 2 scores was 0.72, indicating a strong positive linear relationship. Patients with higher breast satisfaction scores also tended to have higher outcome satisfaction scores, as might be expected. The relationship also was strong for each implant type, with correlation coefficients of 0.73 and 0.72 for silicone gel and saline implants, respectively.
Mean satisfaction and outcome scores by year and implant type were calculated (Figures 11-14) . Implant satisfaction and satisfaction with outcomes remained stable throughout follow-up.
The difference in mean satisfaction and outcome scores for saline vs silicone gel implants was available for all patients in phase 2 (2007-2011). The combined data from these years were used to test the null hypothesis of no difference in mean score between the 2 implant groups. Results of 2-sample t tests (α level = .05) for mean satisfaction and outcome scores are noted in Tables 6 and 7 . There was a marginally significant difference in mean satisfaction scores between the 2 types of implants (P = .046); mean scores for patients who received silicone gel implants were slightly higher than mean scores for recipients of saline implants. Although the difference in mean outcome scores was slightly greater than the difference in mean satisfaction scores, it was not statistically significant (P = .106). For these evaluations, the t test was favored over the z score because the z score is appropriate only when the population standard deviation (σ) is known. For the present data, the population standard deviation was not known and therefore was estimated from the sample standard deviation (s). The t test is appropriate because it accounts for the additional variability encountered when the population standard deviation is estimated from sample data.
Representative BQ questions regarding patient satisfaction and outcomes are shown in Tables 8 and 9 .
Duration of Follow-Up
Of the entire study population, 23.4% (n = 2430) had follow-up of at least 1 year (23.5% of the TAM cohort [n = 2000] and 23.0% of the nonaxillary cohort (n = 430). The proportion of patients with more than 1 year of follow-up was 34.4% among the phase 1 cohort and 13.1% among the phase 2 cohort. Of the phase 1 participants, 16.6% had at least 3 years of follow-up. Patients who did not return for follow-up were those who lived out of state; however, these patients received follow-up phone calls throughout the first 2 months postoperatively. All patients were advised to have annual follow-up examinations of their implants at our office, for the rest of their lives.
Revisions and Untoward events
Overall, 2343 of the 2430 patients did not experience any untoward event. Of the 2000 patients who underwent TAM, 1928 did not require revision surgery. Tables 10 and  11 show the types and incidences of untoward events 
Implant Failure
Overall, deflation was the most common reason for implant-related revisions; there were 87 ruptured implants among the 2430 patients (3.6% of all patients; 1.8% of all implants) ( Table 12 ). The incidence rate was identical for the axillary cohort (72 ruptured implants among 2000 patients; 3.6% of patients) ( Table 13) . With saline implants, rupture is recognized if deflation occurs. However, with gel implants, rupture does not present as deflation, yet it can be assumed if certain clinical changes occur, such as a marked deformity or marked new asymmetry.
dISCuSSION
The BQ mean (SD) score for postoperative satisfaction in the present study (n = 670) was 76.0 (16.6) ( Table 2 ). The higher the score on the scale of 1 to 100, the greater the level of satisfaction. Our BQ satisfaction score compares favorably with that reported by McCarthy et al 4 (score of 70 [SD 23]) from their study of 41 patients who underwent cosmetic BA, 4 and with that of the recent study by Coriddi et al 2 of 59 patients (score of 82.4 [SD 14.3] ). In the latter study, the authors used the 2-sample t test to compare patient satisfaction between the axillary and nonaxillary surgical groups.
For the sake of brevity, the histograms showing the density of distribution are not included in the present report. However, the 2-sample Wilcoxon test provided an accurate reflection of the data. From our outcomes (P < .0001), a The BREAST-Q satisfaction score was calculated for 670 patients who received implants for BA. The score is based on patient responses to 17 items (1 = very dissatisfied, 4 = very satisfied). The item responses were summed and converted into a satisfaction score ranging from 0 to 100. Higher scores indicate greater satisfaction with implant results. The mean (SD) satisfaction score for the 670 respondents was 76.0 (16.6).
surgeon could conclude that it would be worthwhile to offer the axillary approach to nonptotic patients whose anatomy is normal, because these patients were more satisfied than those who received the other approaches.
Comparing Mean satisfaction and Outcome scores Between Patients With saline and silicone Gel Implants
The comparisons of mean satisfaction scores by year, overall and by type of implant (saline vs silicone gel), demonstrate the durability and stability of patient satisfaction over time (Figures 11 and 12 ). Each "implant year" reflects that year's portion of the total number of patients who returned the questionnaire (n = 670) among the 1003 patients who could be contacted postoperatively. The dependent variable was patient satisfaction, and the 2 independent variables were saline and gel implants. The mean (SD) satisfaction score for our 670 patients was 76.0 (16.6) ( Table 2) . Thus, patient satisfaction with BA remains stable over time.
The comparison by year, both overall and for saline vs silicone implants, also shows the long-term durability and stability of patient satisfaction with outcomes (Figures 11  and 12 ). Each "implant year" reflects the portion of the Average scores were used in the event of a tie; z includes a continuity correction of 0.5.
total number of patients who provided this information on their questionnaire (n = 669 of the 1003 contacted postoperatively). (One of the 670 BQ respondents did not provide an outcome score; therefore, this analysis was based on 669 patients.) Coriddi et al 2 concluded that patients who were satisfied with their overall outcomes also were satisfied with the appearance of their breasts and, to a lesser extent, had better psychosocial and sexual well-being. 2 The mean (SD) outcome score for the 669 patients in our series was 80.4 (22.4) ( Table 3) . As mentioned previously, the relationship also was strong for each implant type, with correlation coefficients of 0.73 and 0.72 for silicone gel and saline implants, respectively.
There was a marginally significant difference in mean satisfaction scores between the 2 implant devices (P = .046); scores were slightly higher for patients who received the silicone gel implants ( Table 6 ). The difference between the means was small (3.2 points on the 100-point scale). The small variability of these scores and the relatively large sample size contributed to this being a statistically significant difference. With large sample sizes and small variability (most satisfaction scores were high, so the variability of the satisfaction scores is small), even small differences in means can be statistically significant. Therefore, this very small difference proved statistically significant at the .05 level. More important is the fact that most patients scored their satisfaction and outcomes at a high level, and the differences between the 2 implant groups were very small, indicating a high degree of patient satisfaction regardless of implant type.
Mean outcome scores also were similar between the 2 implant groups (a 3.7-point difference on a 100-point scale), yet slightly higher for those who received saline implants (Table 7) . Although the difference in mean outcome scores was slightly greater than the difference in mean satisfaction scores between the 2 groups, it was not statistically significant (P = .106). This is explained by the larger variability in outcome scores compared with the variability of satisfaction scores. There was no significant difference in outcome scores based on the type of implant.
The follow-up time for patients in phase 1 actually surpasses that of the Food and Drug Administration Summary Data of Breast Implant Clinical Trials; 3-year follow-up was obtained for 16.6% of our phase 1 patients who had saline implants, compared with only 9.6% for the Food and Drug Administration Summary. 19 The revision rate was fairly low in our study. A concern with the nonendoscopic technique is that it may limit the development of an adequate medial pocket and often produce an excessive lateral pocket. To avoid this problem, we took great care to stretch the medial pectoralis muscle fibers and the tendinous attachments. Our revision rate for malposition was 0.9%, and our revision numbers (Tables  11 and 13 ) compare favorably with those of a previous Average scores were used in the event of a tie; z includes a continuity correction of 0.5. 8 who reported on a 20-year cohort series of axillary BA. Reasons for revision in their study included: CC, 1.9% (vs 0.7% in our 10-year TAM cohort); hematoma, 0.12% (vs 0.4%); malposition, 2.97% (vs 1.2%); size change, 2.5% (vs 1.3%); infection, 0% (vs <1%); and rupture, 1.8% of implants (vs 3.6% of implants [but our follow-up was shorter]). If the patient in our study who experienced infection concurrent with an early postoperative tattoo is excluded from the analysis, our rate of infection also would have been zero. The average implant size was 438.5 ± 51.5 cc (range, 270-630 cc) in the study by Huang et al, 8 and 354.3 ± 63.2 cc (range, 150-800 cc) in our 10-year TAM series.
Bartsich et al 20 suggested that the breast harbors significant endogenous bacteria. In their study, quantitative bacterial counts were obtained from intraoperative periareolar, inframammary, and axillary regions of each sampled breast. There was a significant difference in the positive culture rate between the 3 sites, with the lowest bacterial counts being in the axillary region and the highest counts being in the periareolar region. The authors suggested that this information could be helpful in selecting an appropriate incision site. In a recently published, 15-year, long-term study by Stutman et al, 11 there was no statistically significant association between incision location (122 patients had axillary incision) and specific complications such as CC, rippling, implant rupture, hematoma, or infection. Jacobson et al 21 recently reported that the risk of CC was significantly higher with transaxillary incisions than with periareolar or inframammary incisions. However, only 24 transaxillary patients had follow-up, which was of short duration in that study. It is not surprising that the CC rate was higher with TAM, because the implants tend to ride high if the inferior pocket is underdissected. If the implants are tight and riding high postoperatively, an inexperienced examiner could easily mistake these findings for CC. One way to tell the difference between a high-riding implant and CC is to push the implant from side to side. The implant should feel soft if it is high riding. Long-term follow-up is very important because CCs may form over time. Release of the inferior pocket will alleviate this "pseudo-capsule." The senior author of the study by Jacobson et al 21 agreed that highriding implants resulting from the transaxillary technique could have been clinically misjudged to be capsules in their small cohort (personal communication, Dr Scott Spear, April 13, 2013) . This emphasizes the importance of adequate release of the inferior pocket in TAM. A breast band worn 24 hours a day, 7 days per week, for 1 to 3 months usually corrects high-riding implants. 18 It is noteworthy that 3 hematomas occurred in the study by Jacobson et al, 21 all in patients who had inframammary (direct visualization) incisions. All 3 required surgical exploration in the operating room. 21 Even with our nonendoscopic approach, the rate of postoperative hematoma was only 0.4% (7 hematomas among the 2000 TAM-treated patients). This low rate is attributable to blunt dissection, which disrupts the vessel intima, and to irrigation, which diffuses the clotting factors for hemostasis.
Clinical suggestions and Considerations
In the present study, TAM was selected only after the patient had been evaluated thoroughly, with stringent indications in mind, and if the patient had chosen this incision. Almost all qualified patients in this series who had normal anatomy selected TAM in order to avoid breast incision. TAM was the routine procedure for primary BA.
Great care must be taken to preserve the lymphatics when dissecting from the axillary fold skin incision to the edge of the pectoralis major muscle and clavipectoral fascia. The issue of lymphatic interruption has been addressed in several publications, and successful mapping and sentinel lymph node biopsy can be performed after TAM. [22] [23] [24] Clinicians have observed the formation of a fibrous band along the upper arm in up to 15% of patients in large series of axillary BA. 25, 26 These bands reportedly resolved either spontaneously or with massage in all cases, which also has been true in our experience. We suggest routine arm exercises for our patients, not only to help prevent CC but also to prevent or soften the fibrous bands ( Figure 6A,B) . We believe that these bands may result from clotted superficial veins because they tend to extend distally down to the wrist. In our experience, the bands have always resolved by 3 months postoperatively, with or without massage.
Limitations
Several opportunities exist for further study of the patients who received TAM. Although the initial cohort has a theoretical 10-year follow-up period (and follow-up times were calculated meticulously), unless the patients had actually been assessed for the full 10 years, the outcome calculations may not be completely reliable. Any patient requiring reoperation who had moved out of state, or had been referred to a colleague, could have received the secondary operation elsewhere, without having notified us. The follow-up time for phase 2 patients is shorter because their surgeries were performed later. Longer follow-up is necessary to determine accurate rates of complications (especially for the gel cohort and for deflations). Deflation rates for the saline implants in this study will undoubtedly increase over time. Another limitation of the retrospective nature of this study is the lack of follow-up with magnetic resonance imaging or high-resolution ultrasonography in patients who received gel implants. 27 In our study, the BQ was not provided to patients preoperatively. As noted by the authors of a recent comparison Figure 14 . BQ mean outcome score for each year, according to implant type. study in which only postoperative patient responses were assessed for shaped cohesive gel vs round cohesive gel implants, 28 the BQ has been validated to evaluate only postoperative outcomes. The protocol of Macadam et al 28 was similar to that of this study, which compared patient satisfaction and QOL between gel and saline implants. We were able to contact less than half of our study population 11 years later: 1003 (41%) of 2430. Of those contacted, the return rate was 67% (670 of 1003).
Despite these limitations, our BA study is the largest, with the longest follow-up, published to date, and the only study in which patient satisfaction was compared for gel implants vs saline implants. Because the survey of patients extended to 11 years postoperatively, a bias was introduced because not all patients could be contacted. It is possible that the 333 patients who did not return their surveys were dissatisfied, which would yield a positive bias. However, it could also be surmised that dissatisfied patients likely would have returned their surveys as a means to communicate displeasure, which would represent a negative bias.
To date, there is no statistical evidence or data on the success rate of placing a shoelace to form the IMF. Additional study of this procedure is warranted to determine its clinical utility.
CONCLuSIONS
Data from this 10-year, retrospective, comparative review demonstrate that TAM without an endoscope produces long-term patient satisfaction as measured by the BQ. Complication rates were similar to those of other studies. Our findings also show to a statistically significant degree that patient satisfaction is greater after TAM (hidden incision) than after techniques that yield visible incisions. Clearly, the proper choice of BA incision can have a profoundly positive impact on a woman's satisfaction with her breasts and with her surgical outcome, and can substantially improve QOL.
